New Delhi, March 25 -- The Central government is closely monitoring the evolving situation in the Gulf region, with authorities maintaining constant coordination to ensure the safety and well-being of... Read More
Chandigarh, March 25 -- Punjab Kings' Australian stars Marcus Stoinis and Cooper Connolly have officially joined the squad in Mohali. The duo arrived earlier on Wednesday to link up with the rest of t... Read More
Jakarta, March 25 -- Indonesia has recorded notable improvements in the control, management, and safety of Eid al-Fitr homecoming travels this year, with achievements meeting President Prabowo Subiant... Read More
India, March 25 -- The ongoing war between Iran and the United States has sent the entire world into disarray by triggering a global energy crisis. While the missiles and drones may be flying in the s... Read More
Kathmandu, March 25 -- Nearly 2.7 million people who cleared their driving licence tests are still waiting for their cards, years after completing the process, exposing deep inefficiencies in Nepal's ... Read More
Singapore, March 25 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemother... Read More
Singapore, March 25 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safe... Read More
Singapore, March 25 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) ... Read More
Singapore, March 25 -- The Health Sciences Authority received information related to the study titled 'DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig ... Read More
Singapore, March 25 -- The Health Sciences Authority received information related to the study titled 'DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig ... Read More